Romidepsin
Jump to navigation
Jump to search
| Romidepsin | |
|---|---|
| Term | Romidepsin |
| Short definition | romidepsin - (pronounced) (ROH-meh-DEP-sin) drug used to treat adults with cutaneous T-cell lymphoma who are already being treated with at least one other type of systemic therapy. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
romidepsin - (pronounced) (ROH-meh-DEP-sin) drug used to treat adults with cutaneous T-cell lymphoma who are already being treated with at least one other type of systemic therapy. It is also being studied in the treatment of other types of cancer. Romidepsin blocks certain enzymes needed for cell division and can kill cancer cells. It's a type of depsipeptide and a type of histone deacetylase inhibitor. Also called FR901228 and Istodax
External links
- Medical encyclopedia article on Romidepsin
- Wikipedia's article - Romidepsin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski